171 related articles for article (PubMed ID: 15759070)
21. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
22. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
[TBL] [Abstract][Full Text] [Related]
23. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
24. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S
Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746
[TBL] [Abstract][Full Text] [Related]
25. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
26. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Results of a prospective, randomized, longitudinal trial.
Maruff P; Falleti MG; Collie A
Cancer; 2004 Nov; 101(9):2143-4; author reply 2144-5. PubMed ID: 15382092
[No Abstract] [Full Text] [Related]
27. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
28. [Cognitive impairments and breast cancer: a critical review of the literature].
Vandenbossche S; Fery P; Razavi D
Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
[TBL] [Abstract][Full Text] [Related]
29. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
Weis J; Poppelreuter M; Bartsch HH
Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
[TBL] [Abstract][Full Text] [Related]
30. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
Cheung YT; Chui WK; Chan A
Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329
[TBL] [Abstract][Full Text] [Related]
31. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
32. Cognitive effects of chemotherapy-induced menopause in breast cancer.
Vearncombe KJ; Rolfe M; Andrew B; Pachana NA; Wright M; Beadle G
Clin Neuropsychol; 2011 Nov; 25(8):1295-313. PubMed ID: 22047059
[TBL] [Abstract][Full Text] [Related]
33. Neurocognitive changes in cancer survivors.
Correa DD; Ahles TA
Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
[TBL] [Abstract][Full Text] [Related]
34. Accumulating evidence for the effect of chemotherapy on cognition.
Rodin G; Ahles TA
J Clin Oncol; 2012 Oct; 30(29):3568-9. PubMed ID: 22927529
[No Abstract] [Full Text] [Related]
35. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
[TBL] [Abstract][Full Text] [Related]
36. Survivorship and complications of treatment in breast cancer.
Mrozek E; Shapiro CL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992
[TBL] [Abstract][Full Text] [Related]
37. Renaming "chemobrain".
Hurria A; Somlo G; Ahles T
Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
[TBL] [Abstract][Full Text] [Related]
38. Sexuality and body image in younger women with breast cancer.
Schover LR
J Natl Cancer Inst Monogr; 1994; (16):177-82. PubMed ID: 7999462
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
Dutta V
J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
[TBL] [Abstract][Full Text] [Related]
40. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
Vassilopoulou-Sellin R; Theriault RL
J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
